GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » Net Income Including Noncontrolling Interests

Hunan Fangsheng Pharmaceutical Co (SHSE:603998) Net Income Including Noncontrolling Interests : ¥270 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Hunan Fangsheng Pharmaceutical Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Hunan Fangsheng Pharmaceutical Co's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was ¥89 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was ¥270 Mil.

Hunan Fangsheng Pharmaceutical Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Hunan Fangsheng Pharmaceutical Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Fangsheng Pharmaceutical Co Net Income Including Noncontrolling Interests Chart

Hunan Fangsheng Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.78 69.92 276.71 179.62 249.85

Hunan Fangsheng Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.27 67.38 91.76 22.45 88.73

Hunan Fangsheng Pharmaceutical Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥270 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Fangsheng Pharmaceutical Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Hunan Fangsheng Pharmaceutical Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Fangsheng Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
SHSE:600351 SHSE:603520 BJSE:832735 SHSE:688247 SHSE:600479 SHSE:688799 SZSE:002728 SHSE:600829 SZSE:002393 SZSE:301509 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 789, Lusong Road, Changsha High-tech Zone, Changsha, CHN
Website
http://www.fangsheng.com.cn
Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.
Executives
He Shi senior management
Xiao Han Qing senior management
Liu Xin He senior management
Chen Bo Director
Chen Ai Chun Director
Li Zhi Heng senior management
Zhou Wei En senior management
Zhang Qing Hua Director
Huang Min Director
Zhou Xiao Li senior management
Fang Jin Cheng Director
Fang Chuan Long Supervisors
Tan Yuan Ming Director

Hunan Fangsheng Pharmaceutical Co Headlines

No Headlines